These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Lipocortin 1 and hypothalamo-pituitary function in the rat. Taylor AD; Loxley HD; Flower RJ; Buckingham JC Ann N Y Acad Sci; 1994 Nov; 746():441-5. PubMed ID: 7529974 [No Abstract] [Full Text] [Related]
43. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362 [TBL] [Abstract][Full Text] [Related]
44. Ultrastructure of somatotrophs of rats with median eminence lesions: studies in basal conditions and after thyrotropin-releasing hormone stimulation. Rossi GL; Probst D; Panerai AE; Cocchi D; Locatelli V; Müller EE Neuroendocrinology; 1979; 29(2):100-9. PubMed ID: 116140 [TBL] [Abstract][Full Text] [Related]
45. Use of the reverse hemolytic plaque assay to study the regulation of anterior lobe adrenocorticotropin (ACTH) secretion by ACTH-releasing factor, arginine vasopressin, angiotensin II, and glucocorticoids. Childs GV; Burke JA Endocrinology; 1987 Feb; 120(2):439-44. PubMed ID: 3026776 [TBL] [Abstract][Full Text] [Related]
46. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. Rivier C; Rivier J; Mormede P; Vale W Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290 [TBL] [Abstract][Full Text] [Related]
47. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively. Link H; Dayanithi G; Föhr KJ; Gratzl M Endocrinology; 1992 Apr; 130(4):2183-91. PubMed ID: 1312449 [TBL] [Abstract][Full Text] [Related]
48. [The hormonal indices of the reactivity of the central links in the hypothalamo-hypophyseal-adrenocortical system of rats during postnatal ontogeny]. Danilova OA; Chernigovskaia EV; Chetverukhin VK Zh Evol Biokhim Fiziol; 1991; 27(3):308-13. PubMed ID: 1662850 [TBL] [Abstract][Full Text] [Related]
49. Immunoreactive substance P content in median eminence and pituitary gland during oestrus, dioestrus and after anterior hypothalamic deafferentation. Antonowicz U; Jakubowska-Naziembło B; Cannon D; Powell D Endokrinologie; 1982 Feb; 79(1):25-34. PubMed ID: 6177528 [TBL] [Abstract][Full Text] [Related]
50. What is the mechanism of vasopressin in causing corticotropin release? Franzén G Endokrinologie; 1971 Apr; 57(3):338-42. PubMed ID: 4325993 [No Abstract] [Full Text] [Related]
51. Influence of hypothalamic extract on the uptake of steroid hormones by the anterior pituitary gland in rats. Hegedüs I; Endröczi E Prog Brain Res; 1975; 42():329. PubMed ID: 1197737 [No Abstract] [Full Text] [Related]
52. Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphin release: effects of acute and chronic stress. Young EA; Akil H Endocrinology; 1985 Jul; 117(1):23-30. PubMed ID: 2988916 [TBL] [Abstract][Full Text] [Related]
53. Release of vasopressin from the microdissected median eminence of the rat. Bény JL; Baertschi AJ Brain Res; 1981 Feb; 206(2):469-73. PubMed ID: 6260283 [No Abstract] [Full Text] [Related]
54. Interaction of rat adenohypophyseal vasopressin receptors with vasopressin analogues substituted at positions 7 and 1: dissimilarity from the V1 vasopressin receptor. Knepel W; Götz D; Fahrenholz F Neuroendocrinology; 1986; 44(3):390-6. PubMed ID: 3027602 [TBL] [Abstract][Full Text] [Related]
55. Growth hormone releasing activity in rhesus monkeys of crude ovine stalk median eminence extracts. Smith GP; Katz SH; Root AW; Dhariwal AP; Bongiovanni A; Eberlein W; McCann SM Endocrinology; 1968 Jul; 83(1):25-32. PubMed ID: 4968976 [No Abstract] [Full Text] [Related]
56. In vitro CRF activity of vasopressin analogs is not related to pressor activity. Knepel W; Homolka L; Vlaskovska M Eur J Pharmacol; 1983 Jul; 91(1):115-8. PubMed ID: 6311567 [TBL] [Abstract][Full Text] [Related]
57. Determination of dopamine in the anterior pituitary as an index of tuberoinfundibular dopaminergic function. Apud J; Cocchi D; Iuliano E; Casanueva F; Müller EE; Racagni G Brain Res; 1980 Mar; 186(1):226-31. PubMed ID: 6244059 [No Abstract] [Full Text] [Related]
58. Terminals of reserpine-sensitive vasopressin-neurophysin neurons in the external layer of the rat median eminence. Seybold V; Elde R; Hökfelt T Endocrinology; 1981 May; 108(5):1803-9. PubMed ID: 7011784 [TBL] [Abstract][Full Text] [Related]
59. Properties of the corticotrophin-releasing factor of the rat median eminence. Chan LT; Schaal SM; Saffran M Endocrinology; 1969 Oct; 85(4):644-51. PubMed ID: 4308476 [No Abstract] [Full Text] [Related]
60. Electrophysiological indications of a 'vasopressinergic' innervation of the median eminence. Blume HW; Pittman QJ; Renaud LP Brain Res; 1978 Oct; 155(1):153-8. PubMed ID: 80254 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]